TBXU — Direxion Daily Biotech Top 5 Bull 2X ETF
Data updated: 2026-06-29
TBXU — Direxion Daily Biotech Top 5 Bull 2X ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Leveraged · $2.95M AUM · 0.97% expense ratio. From SEC regulatory filings.
TBXU Fund Overview
TBXU — Direxion Daily Biotech Top 5 Bull 2X ETF is a US ETF managed by Direxion Shares ETF Trust, categorised as Leveraged. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Direxion Shares ETF Trust
- Category: Leveraged
- Assets under management: $2.95M
- Ticker: TBXU
- SEC CIK: 0001424958
- SEC series ID: S000092912
- Share class ID: C000260962
TBXU Holdings
Top 8 holdings of Direxion Daily Biotech Top 5 Bull 2X ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Dreyfus Government Cash Manage | 30.03% |
| Goldman Financial | 25.55% |
| Argenx SE - ADR | 10.09% |
| Regeneron Pharmaceuticals, Inc. | 8.55% |
| Amgen Inc. | 8.54% |
| Vertex Pharmaceuticals, Inc. | 8.22% |
| Gilead Sciences Inc. | 8.14% |
| Goldman Sachs Liq Es Fd A | 5.42% |
TBXU Portfolio Allocation
Asset-class allocation of Direxion Daily Biotech Top 5 Bull 2X ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Cash & Equivalents | 61.0% |
| Equity | 43.5% |
TBXU Performance
Total returns for TBXU (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -4.5% |
TBXU Costs and Fees
TBXU costs about $97 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.97%
- Gross expense ratio: 0.99%
- Brokerage commissions: 36.54 bps of average net assets (SEC N-CEN)
TBXU Cashflows
Over the 12 months to 2026-04, Direxion Daily Biotech Top 5 Bull 2X ETF had net inflows of $2.32M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | −$869.56K |
| 2026-01 | $0 |
| 2025-12 | $812.53K |
| 2025-11 | −$792.01K |
TBXU Debt Constituents
No individual debt constituents are reported in Direxion Daily Biotech Top 5 Bull 2X ETF's latest SEC N-PORT filing.
TBXU Prospectus and SEC Filings
Official Direxion Daily Biotech Top 5 Bull 2X ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Leveraged funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.